Quantification of Parkinson's Disease Patients As a Biomarker for Classification, Prediction and Response to Treatment
At a glance
Conditions
NCT06586320
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Dartmouth Hitchcock medical center
Manchester, New Hampshireno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Anas Hannoun, MD · PRINCIPAL_INVESTIGATOR · Dartmouth Hitchcock medical center, Manchester
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Quantification of current IPD motor symptoms using kinetic tremor and Dyskinesia testDay 1
ANLIVA® Hand Movement score of kinetic tremor test and dyskinesia test will be measured. Measurements are done on subjects upper limb movements. SD score of kinetic tremor test and dyskinesia test will be assessed by assessors. SD is acronym for Stardots-Dartmouth score. The SD score will be used to benchmark the ANLIVA® device assessments as a nonreference standard. Minimum value is 0; maximum value is 4. A higher value on the SD score means more movement disorder.